Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Multi-Employer Property Trust (MEPT) is a multi-billion dollar open-end real estate equity fund that invests in a diversified portfolio of institutional-quality properties across the United States. While not a biotechnology or pharmaceutical company, MEPT is a major provider of infrastructure for the life sciences industry, owning and developing significant laboratory, R&D, and office spaces in primary biotech clusters such as Boston, Seattle, and San Francisco. The fund is primarily owned by Taft-Hartley and public employee pension plans and is managed by BentallGreenOak (formerly Bentall Kennedy). MEPT is notably recognized for its commitment to sustainable development and its policy of using union labor for all construction and maintenance projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multi-Employer Property Trust.